DK1196440T3 - Terapeutiske peptider afledt af subsekvenser af BPI - Google Patents
Terapeutiske peptider afledt af subsekvenser af BPIInfo
- Publication number
- DK1196440T3 DK1196440T3 DK00943110T DK00943110T DK1196440T3 DK 1196440 T3 DK1196440 T3 DK 1196440T3 DK 00943110 T DK00943110 T DK 00943110T DK 00943110 T DK00943110 T DK 00943110T DK 1196440 T3 DK1196440 T3 DK 1196440T3
- Authority
- DK
- Denmark
- Prior art keywords
- bpi
- sequences
- sub
- peptides derived
- therapeutic peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 102100033735 Bactericidal permeability-increasing protein Human genes 0.000 abstract 2
- 101000871785 Homo sapiens Bactericidal permeability-increasing protein Proteins 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/344,219 US6515104B1 (en) | 1999-06-25 | 1999-06-25 | Therapeutic peptide-based constructs derived from domain II of bactericidal/permeability-increasing protein |
| US09/344,827 US6423825B1 (en) | 1999-06-25 | 1999-06-25 | Therapeutic derivative compounds derived from domain II of bactericidal/permeability-increasing protein |
| PCT/US2000/017358 WO2001000655A2 (fr) | 1999-06-25 | 2000-06-23 | Constructions peptidiques therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1196440T3 true DK1196440T3 (da) | 2004-07-12 |
Family
ID=26993808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00943110T DK1196440T3 (da) | 1999-06-25 | 2000-06-23 | Terapeutiske peptider afledt af subsekvenser af BPI |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1196440B1 (fr) |
| JP (1) | JP4707911B2 (fr) |
| AT (1) | ATE260934T1 (fr) |
| AU (1) | AU782428B2 (fr) |
| CA (1) | CA2377209C (fr) |
| DE (1) | DE60008749T2 (fr) |
| DK (1) | DK1196440T3 (fr) |
| WO (1) | WO2001000655A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1339424A2 (fr) | 2000-12-01 | 2003-09-03 | XOMA Technology Ltd. | Modulation de la proliferation de pericytes |
| JP2006528645A (ja) * | 2003-07-23 | 2006-12-21 | ゾーマ テクノロジー リミテッド | ざ瘡の処置のための、ｘｍｐ−６２９の使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4139863B2 (ja) * | 1993-03-12 | 2008-08-27 | ゾーマ テクノロジー リミテッド | 殺菌性／透過性が向上したタンパク質の機能領域に由来する生物学的に活性なペプチドおよびその使用 |
| US5733872A (en) * | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| WO1995005393A2 (fr) * | 1993-08-18 | 1995-02-23 | Morphosys Gesellschaft Für Proteinoptimierung Mbh | Peptides liant et neturalisant les lipopolysaccharides |
| AU759636B2 (en) * | 1997-07-31 | 2003-04-17 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
-
2000
- 2000-06-23 WO PCT/US2000/017358 patent/WO2001000655A2/fr not_active Ceased
- 2000-06-23 AT AT00943110T patent/ATE260934T1/de not_active IP Right Cessation
- 2000-06-23 DK DK00943110T patent/DK1196440T3/da active
- 2000-06-23 JP JP2001518656A patent/JP4707911B2/ja not_active Expired - Fee Related
- 2000-06-23 CA CA2377209A patent/CA2377209C/fr not_active Expired - Lifetime
- 2000-06-23 EP EP00943110A patent/EP1196440B1/fr not_active Expired - Lifetime
- 2000-06-23 DE DE60008749T patent/DE60008749T2/de not_active Expired - Lifetime
- 2000-06-23 AU AU57628/00A patent/AU782428B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2377209C (fr) | 2011-08-23 |
| JP2003507470A (ja) | 2003-02-25 |
| DE60008749D1 (de) | 2004-04-08 |
| AU5762800A (en) | 2001-01-31 |
| CA2377209A1 (fr) | 2001-01-04 |
| WO2001000655A2 (fr) | 2001-01-04 |
| ATE260934T1 (de) | 2004-03-15 |
| JP4707911B2 (ja) | 2011-06-22 |
| EP1196440A2 (fr) | 2002-04-17 |
| WO2001000655A3 (fr) | 2002-01-24 |
| DE60008749T2 (de) | 2005-03-10 |
| AU782428B2 (en) | 2005-07-28 |
| EP1196440B1 (fr) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE525082T1 (de) | Compstatin-analoga mit verbesserter wirkung | |
| CY1108007T1 (el) | Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης | |
| DK0960127T3 (da) | Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf | |
| ATE411082T1 (de) | Neue verwendung von kurzkettigen carbonsäuren | |
| DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| DK1478328T3 (da) | Bioaktive keratinpeptider | |
| ATE551048T1 (de) | Proteinhydrolysate enthaltende kosmetische zusammensetzungen | |
| ATE330017T1 (de) | Kallikrein gen | |
| EA200700973A1 (ru) | Слитый белок, содержащий домен bh3 белка «вh3-только» | |
| ATE322503T1 (de) | Gefrierschutzprotein | |
| DE502004011395D1 (de) | Protein-bindende doxorubicin-peptid-derivate | |
| EP1548107A4 (fr) | Chromoproteine et fluoroproteines | |
| DE69931482D1 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
| TR200002101T2 (tr) | Dondurulmuş gıda ürünü. | |
| ATE323763T1 (de) | Dna & protein bindende miniatur proteine | |
| ES2507094T3 (es) | Proteína específica del timo | |
| DE50206480D1 (de) | Antimikrobiell wirkendes peptid | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| BR9711540A (pt) | Inibidores de protease proteìnico estabilizados e variantes dos mesmos | |
| DK1196440T3 (da) | Terapeutiske peptider afledt af subsekvenser af BPI | |
| SG165168A1 (en) | New adenoviruses, nucleic acids coding therefor and their use | |
| DE69938130D1 (de) | Neue peptide | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| WO2002030975A3 (fr) | Composé fongicide | |
| CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του |